PTC Therapeutics | PTCT - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Cytokinetics USD 8.19B 420M 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.28B 30M 2026-03
TG Therapeutics USD 5.31B 572M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Xencor USD 893M 200M 2026-03